The Referral Moves in Viber. The Melasma Consult Waits Until October.

The same nurse who tells a patient there is no dermatology slot until October can, in a private Viber group, send you a supplier for glutathione drips within the hour. One line is booked solid for months. The other clears same-day, cash or GCash, no wait.

This is not a scandal about a few rogue accounts. It is how the traffic actually runs inside the workforce that is supposed to know better.

The list they manage, and the list they use

Public dermatology in most tertiary hospitals is triaged for disease: eczema, psoriasis, skin cancer screening, the melasma consult that keeps getting pushed. Cosmetic lightening is not the priority, and it shouldn't be. Nurses run that queue every shift. They know exactly how long the wait is because they are the ones apologizing for it.

Off the clock, the group chats tell a different story. IV glutathione at a rate for colleagues. A dermatologist friend who does after-hours drips. A supplier of vials with no clear label, sold on trust and a shared employee ID. The referral carries weight precisely because it comes from someone in scrubs.

Why the uniform sells it

A whitening pitch from a random Shopee seller reads as risk. The same pitch from a nurse reads as a tip from someone who checked your labs. That is the whole trade. The credential does the marketing for free.

The FDA has not approved IV glutathione for skin lightening. The known risks include kidney strain, thyroid problems, and infection from unsterile injection. Nurses have read this. Some are still passing the contact along, and some are on the drip themselves, because the same colorism that sits in every casting call and every dating app sits in the break room too.

Fair skin still reads as clean, promotable, marriageable. A brown nurse gets called maganda na sana kung mas maputi. The people who staff the wards absorbed that ranking growing up like everyone else. Wearing white does not delete it.

The cost sits on the patient

Follow the money and it lands somewhere ugly. A patient with actual disease waits months for the public slot. A patient with cash and the right group-chat invite skips the line entirely, injecting something unregulated, sold by the exact profession trained to warn against it.

The nurse earns a small cut or a discount on their own vials. The supplier moves product with zero storefront and zero accountability. If a reaction sends someone to the ER, there is no receipt, no consent form, no name on a bottle.

Nobody is asking nurses to fix a beauty standard the whole country marinated in. But the hospital that runs a dermatology waitlist has a duty about what its staff sell in the parking lot. When the referral moves faster than the consult, the workforce is running two lines: the slow one for the sick, the fast one for the vain, and taking a cut on the fast one. That is the bargain patients never agreed to.